2019
DOI: 10.1016/j.bbrc.2019.05.025
|View full text |Cite
|
Sign up to set email alerts
|

MTA2 promotes HCC progression through repressing FRMD6, a key upstream component of hippo signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
24
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(25 citation statements)
references
References 35 publications
1
24
0
Order By: Relevance
“…20,21 MTA2 acts as a central hub for cytoskeletal organization and transcription and provides a link between nuclear and cytoskeletal organization. It was also found to be significantly upregulated and to function as an oncogene in a wide range of malignancies such as renal cancer, 22 hepatocellular carcinoma, 23 and pancreatic ductal adenocarcinoma. 24 Moreover, MTA2 expression is regulated at the posttransciptional level in gastric cancer, 25 and the long noncoding RNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through targeting MTA2.…”
Section: Discussionmentioning
confidence: 99%
“…20,21 MTA2 acts as a central hub for cytoskeletal organization and transcription and provides a link between nuclear and cytoskeletal organization. It was also found to be significantly upregulated and to function as an oncogene in a wide range of malignancies such as renal cancer, 22 hepatocellular carcinoma, 23 and pancreatic ductal adenocarcinoma. 24 Moreover, MTA2 expression is regulated at the posttransciptional level in gastric cancer, 25 and the long noncoding RNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through targeting MTA2.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, miR-454-3p inhibitor reversed the downregulation of FRMD6 protein level induced by linc00887 knockdown. FRMD6 was reported to be a key upstream component of the Hippo signaling pathway [28,29], and Hippo signaling pathway is considered a key carcinogenic pathway for multiple tumors [28,30,31] or asthma treatment [32]. This Hippo pathway is one of the main conservative mechanisms controlling cell contact inhibition, organ size control and cancer development [33], and the downstream of the signaling pathway is transcriptional coactivator yorkie (Yki)/the transcriptional coactivator Yes-associated protein (YAP)/TAZ transcriptional activator [34].…”
Section: Discussionmentioning
confidence: 99%
“…Based on the data from GEPIA and our HCC samples from clinical patients, the major components (YAP and TAZ) in HIPPO pathway were closely associated with the FGF21 and IL-17A expression levels in regard to the prognosis. Accumulating evidence suggests that HIPPO pathway plays a critical role linking the NASH-HCC transition 54 - 56 . Further study is needed to address the accurate role of YAP and TAZ, which could be important carcinogenetic signaling involved in the NASH-HCC initiation and progression.…”
Section: Discussionmentioning
confidence: 99%